by Truveta staff | Aug 22, 2023 | Data
RSV season, which typically starts in fall and peaks in winter, could look very different this year. With newly approved vaccines for older adults and pregnant women and an immunization for infants poised to roll out, public health experts are optimistic about...
by Truveta staff | Aug 9, 2023 | Data, News
Today Truveta announced the addition of new in-depth medication dispense data to help researchers study safety and effectiveness, medication adherence, and adverse events. Medication dispense data helps researchers understand patients’ actual use of medications. With...
by Truveta staff | Aug 4, 2023 | Data, Technology
Medical devices play a key role in saving lives and improving patient outcomes on a global scale, yet most information about specific device safety and effectiveness is derived from pre-market clinical trials. Understanding medical device effectiveness in the...
by Truveta staff | Jul 31, 2023 | Data
Rare diseases as a category aren’t that rare if you consider they impact 30 million Americans and 400 million people around the world. Not to mention their families, who often become caregivers. Yet, with nearly 7,000 rare diseases (identified as of today…), each is...
by Truveta staff | Jul 17, 2023 | Data, Technology
Using real-world data to understand a patient’s journey through the healthcare ecosystem can be challenging, particularly for rare or less common diseases. The relevant data are often fragmented, incomplete, and inaccessible—further limiting the data available to...
by Truveta staff | Jun 15, 2023 | Data
We are entering a new era of Alzheimer’s Disease research. Researchers from the University of Tsukuba in Japan along with IBM Research have recently developed a mobile app to detect Alzheimer’s using speech data. New research suggests deep brain stimulation while...
